Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mitsubishi sets up marketing network for cholesterol-binding agent; launch anticipated this year

Jan. 14, 1999

Asta Medica files for approval of LHRH antagonist and establishes marketing partnership

Jan. 14, 1999

European study establishes long-term efficacy and safety of alprostadil alfadex

Jan. 13, 1999

GelTex reports success with first- and second-generation cholesterol-lowering compounds

Jan. 13, 1999

Taiho synthesizes novel compounds for bone metabolism disorders

Jan. 13, 1999

New cysteine protease inhibitors from SB for osteoporosis, arthritis, etc.

Jan. 13, 1999

ATP citrate (pro-S)-lyase confirmed as potential therapeutic target in lipid disorders

Jan. 12, 1999

Milestone reached in Metabasis-Sankyo diabetes collaboration

Jan. 12, 1999

New market approvals for Zestril as Rx for renal complications of diabetes

Jan. 12, 1999

FDA approves world's smallest estrogen transdermal patch

Jan. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...